SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Change in Accured Expenses (2021 - 2026)

SeaStar Medical Holding's (ICU) quarterly Change in Accured Expenses came in at $629000.0 in Q1 2026, up 838.81% YoY from $67000.0 in Q1 2025, and down 44.87% on a QoQ basis from $1.1 million in Q4 2025.

SeaStar Medical Holding (ICU) Change in Accured Expenses (2021 - 2026) Analysis & Trends

SeaStar Medical Holding (ICU) has 6 years of Change in Accured Expenses data on file, last reported at $629000.0 in Q1 2026.

  • Quarterly Change in Accured Expenses rose 838.81% year-over-year to $629000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $562000.0 (down 70.74% YoY) and the FY2024 annual result came in at $1.9 million, changed N/A from the prior year.
  • Change in Accured Expenses fell to $629000.0 in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q4 2022 to a low of -$1.4 million in Q2 2025.
  • A 5-year average of $305133.3 and a median of $195000.0 in 2022 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2025 — Change in Accured Expenses sank 305.39% — and 2026, when it soared 838.81%.
  • Tracing ICU's Change in Accured Expenses over 5 years: stood at $1.6 million in 2022, then plunged by 144.29% to -$698000.0 in 2023, then surged by 297.71% to $1.4 million in 2024, then retreated by 17.32% to $1.1 million in 2025, then slumped by 44.87% to $629000.0 in 2026.
  • The last three Change in Accured Expenses figures came in at $629000.0 (Q1 2026), $1.1 million (Q4 2025), and $164000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00 571,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 571,000.00
Jun 30, 2026 571,000.00
Mar 31, 2026 629,000.00
Mar 31, 2026 629,000.00
Dec 31, 2025 1.14 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 164,000.00
Sep 30, 2025 164,000.00
Jun 30, 2025 -1.37 Mn
Jun 30, 2025 -1.37 Mn
Mar 31, 2025 67,000.00
Mar 31, 2025 67,000.00
Dec 31, 2024 1.38 Mn
Dec 31, 2024 1.38 Mn
Sep 30, 2024 -194,000.00
Sep 30, 2024 -194,000.00
Jun 30, 2024 668,000.00
Jun 30, 2024 668,000.00
Mar 31, 2024 21,000.00
Mar 31, 2024 21,000.00